Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Article

cited authors

  • Ting, David T; Dey, Bimalangshu; Chaudhary, Ahmed; Colby, Christine; Power, Karen; McAfee, Steven; Ballen, Karen; Attar, Eyal; Saidman, Susan; Preffer, Frederick; Sackstein, Robert; Shaffer, Juanita; Sykes, Megan; Spitzer, Thomas R

fiu authors

publication date

  • November 16, 2005

Digital Object Identifier (DOI)

start page

  • 3665

end page

  • 3665


  • 106


  • 11